Therapeutic Neodymium-doped Yttrium-Aluminum-Garnet (Nd:YAG) Laser Vitreolysis for Vitreous Floaters - A Study to Quantify Visual Quality of Life, Vitreous Structure, and Vision Before and After Nd:YAG Laser Vitreolysis in Patients With Vision Degrading Myodesopsia
VMR Consulting, Inc.
Summary
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Only one eye per patient will be included in this study * Able and willing to give informed consent * Age ≥18 years * Suffering from symptomatic vitreous floaters * Floaters arising from either/both: * myopic vitreopathy * posterior vitreous detachment * Floaters meeting the following characteristics: * Present for ≥3 months * One single or more dense and well-defined vitreous opacities, * A Weiss Ring or opacities which are within the safety area, at least 3mm away from the retina and 6mm away from the lens * Visible on contact lens biomicroscopy Exclusio…
Interventions
- DeviceNeodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy
Nd:YAG laser treatment(s) for Vision Degrading Myodesopsia (clinically significant vitreous floaters) in eyes with vitreous opacities due to myopic vitreopathy and posterior vitreous detachment (PVD).
Location
- VMR Institute for Vitreous Macula RetinaHuntington Beach, California